Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Aug;37(5):554-9.
doi: 10.1111/j.1365-2990.2011.01174.x.

A case of Gerstmann-Sträussler-Scheinker disease with a novel six octapeptide repeat insertion

A Vital, J-L Laplanche, J-R Bastard, X Xiao, W-Q Zou, C Vital
Case Reports

A case of Gerstmann-Sträussler-Scheinker disease with a novel six octapeptide repeat insertion

A Vital et al. Neuropathol Appl Neurobiol. 2011 Aug.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
a Haematoxylin-eosin stained section of the cerebellum showing multicentric amyloid plaques in the molecular layer, each surrounded by radially arranged bundles (insert); b these deposits are fluorescent under UV light after thioflavine S staining; c they are stained by Congo red, d with a yellow-green birefringence; e PrP-immunostaining is strongly positive on the periphery of amyloid plaques; f GFAP-positive astrocytic gliosis is marked in the molecular layer of the cerebellum (bar a, e, f 80 μm; b 65 μm; a insert, c, d 40μm)
Fig. 2
Fig. 2
A: Western blot analysis of insoluble PrP on brain homogenates labeled as 1 (frontal cortex), 2 (temporal cortex), 3 (occipital cortex), and 8 (cerebellum). A 5 μl brain homogenate each was detected by Western blotting with 3F4 after treated with or without proteinase K (PK) at 50 μg/ml at 37°C for 1 h. T1: PrPSc type 1 and T2: PrPSc type 2 from sporadic Creutzfeldt-Jakob disease. B: Less exposed film showing a better gel profile of PrP from the cerebellum (8) treated with or without PK.
See this image and copyright information in PMC

References

    1. Hainfellner JA, Brantner-Inthaler S, Cervenakova L, Brown P, Kitamoto T, Tateishi J, Diringer H, Liberski PP, Regele H, Feucht M, Mayr N, Wessely P, Summer K, Seitelberger F, Budka H. The original Gerstmann-Sträussler-Scheinker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol. 1995;5:201–211. - PubMed
    1. Wadsworth JDF, Joiner S, Linehan JM, Cooper S, Powell C, Mallinson G, Buckell J, Gowland I, Asante EA, Budka H, Brandner S, Collinge J. Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein. Brain. 2006;129:1557–1569. - PubMed
    1. Ironside JW, Ghetti B, Head MW, Piccardo P, Will RG. Prion diseases. In: Love S, Louis DN, Ellison DW, editors. Greenfield's Neuropathology. 8th edn. Hodder Arnold; London: 2008. pp. 1197–1273.
    1. Webb TEF, Poulter M, Beck J, Uphill J, Adamson G, Campbell T, Linehan J, Powell C, Brandner S, Pal S, Siddique D, Wadsworth JD, Joiner S, Alner K, Petersen C, Hampson S, Rhymes C, Treacy C, Storey E, Geschwind MD, Nemeth AH, Wroe S, Collinge J, Mead S. Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain. 2008;131:2632–2646. - PMC - PubMed
    1. Itoh Y, Yamada M, Hayakawa M, Shozawa T, Tanaka J, Matsushita M, Kitamoto T, Tateishi J, Otomo E. A variant of Gerstmann-Sträussler-Scheinker disease carrying codon 105 mutation with codon 129 polymorphism of the prion gene: a clinicopathological study. J Neurol Sci. 1994;127:77–86. - PubMed

Publication types